Acute Responses to Walking, Stair Climbing, and Functional Circuit Exercise
4. september 2026 oppdatert av: Ramazan Bayer, Malatya Turgut Ozal University
Acute Metabolic, Respiratory, and Neuromotor Responses to Walking, Stair Climbing, and Functional Circuit Exercise in Sedentary Individuals: A Heart Rate-Controlled Randomized Crossover Study
This study evaluated the acute physiological responses to three different exercise modalities in sedentary young men. Participants completed walking, stair climbing, and functional circuit exercise sessions in a randomized crossover design. Each exercise session lasted 20 minutes and was performed at a target intensity of 50% heart rate reserve (±5 beats/min), with at least 72 hours between sessions.
The study compared acute respiratory, metabolic, and neuromotor responses to the three exercise modalities. Pulmonary function was assessed using spirometry, blood lactate concentration was measured using capillary blood samples, and countermovement jump performance was assessed as an indicator of neuromuscular performance. Heart rate was continuously monitored during each exercise session.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
30
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Malatya
-
Malatya, Malatya, Tyrkia (Türkiye), 44100
- Malatya Turgut Ozal University
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Male sex.
- Aged 18-30 years.
- Classified as sedentary/insufficiently active according to the study eligibility criteria.
- Able to safely complete the exercise protocols and study assessments.
- Provided voluntary informed consent.
Exclusion Criteria:
- Current cigarette or electronic cigarette use.
- Known cardiovascular, respiratory, or metabolic disease.
- Regular medication use that could affect physiological responses to exercise.
- Acute infection within the previous 2 weeks.
- Musculoskeletal conditions that could interfere with safe participation in the exercise protocols.
- Any condition requiring medical evaluation before exercise participation.
- Inability to obtain acceptable baseline spirometry measurements according to the study procedures.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: WP-SP-FCP Sequence
Participants completed the Walking Protocol first, followed by the Stair Climbing Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
|
|
Eksperimentell: WP-FCP-SP Sequence
Participants completed the Walking Protocol first, followed by the Functional Circuit Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
|
|
Eksperimentell: SP-WP-FCP Sequence
Participants completed the Stair Climbing Protocol first, followed by the Walking Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
|
|
Eksperimentell: SP-FCP-WP Sequence
Participants completed the Stair Climbing Protocol first, followed by the Functional Circuit Protocol and then the Walking Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
|
|
Eksperimentell: FCP-WP-SP Sequence
Participants completed the Functional Circuit Protocol first, followed by the Walking Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
|
|
Eksperimentell: FCP-SP-WP Sequence
Participants completed the Functional Circuit Protocol first, followed by the Stair Climbing Protocol and then the Walking Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Forced Expiratory Volume in One Second (FEV1)
Tidsramme: Baseline and 5 minutes after each exercise session
|
Forced expiratory volume in one second (FEV1) was measured by spirometry before and 5 minutes after each exercise condition.
The primary outcome was the change in FEV1 (ΔFEV1), calculated as post-exercise FEV1 minus pre-exercise FEV1 and expressed in liters (L).
Measurements were obtained following standardized spirometry procedures.
|
Baseline and 5 minutes after each exercise session
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Forced Vital Capacity (FVC)
Tidsramme: Baseline and 5 minutes after each exercise session
|
Forced vital capacity (FVC) was measured by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in FVC (ΔFVC), calculated as post-exercise FVC minus pre-exercise FVC and expressed in liters (L).
|
Baseline and 5 minutes after each exercise session
|
|
Change in FEV1/FVC Ratio
Tidsramme: Baseline and 5 minutes after each exercise session
|
The FEV1/FVC ratio was assessed by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in FEV1/FVC ratio (ΔFEV1/FVC), calculated as the post-exercise value minus the pre-exercise value.
|
Baseline and 5 minutes after each exercise session
|
|
Change in Peak Expiratory Flow (PEF)
Tidsramme: Baseline and 5 minutes after each exercise session
|
Peak expiratory flow (PEF) was measured by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in PEF (ΔPEF), calculated as the post-exercise PEF minus the pre-exercise PEF and expressed in liters per second (L/s).
|
Baseline and 5 minutes after each exercise session
|
|
Change in Blood Lactate Concentration
Tidsramme: Baseline and 3 minutes after each exercise session
|
Capillary blood lactate concentration was measured before exercise and 3 minutes after each exercise condition.
The outcome was the change in blood lactate concentration (ΔLactate), calculated as the post-exercise value minus the pre-exercise value and expressed in millimoles per liter (mmol/L).
|
Baseline and 3 minutes after each exercise session
|
|
Change in Countermovement Jump Height (CMJ)
Tidsramme: Baseline and immediately after post-exercise spirometry initiated at 5 minutes after each exercise session
|
Countermovement jump (CMJ) height was assessed before and after each exercise condition.
The outcome was the change in CMJ height (ΔCMJ), calculated as the post-exercise value minus the pre-exercise value and expressed in centimeters (cm).
|
Baseline and immediately after post-exercise spirometry initiated at 5 minutes after each exercise session
|
|
Mean Heart Rate During Exercise
Tidsramme: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
Mean heart rate was calculated across the exercise period and expressed in beats per minute (bpm).
|
During each 20-minute exercise session
|
|
Maximum Heart Rate During Exercise
Tidsramme: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
Maximum heart rate was defined as the highest heart rate recorded during the exercise period and expressed in beats per minute (bpm).
|
During each 20-minute exercise session
|
|
Time Spent in the Target Heart Rate Range
Tidsramme: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
The outcome was the percentage of exercise time during which heart rate remained within ±5 beats/min of the individualized target heart rate corresponding to 50% heart rate reserve (HRR)
|
During each 20-minute exercise session
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
22. juni 2026
Primær fullføring (Faktiske)
5. august 2026
Studiet fullført (Faktiske)
5. august 2026
Datoer for studieregistrering
Først innsendt
1. september 2026
Først innsendt som oppfylte QC-kriteriene
4. september 2026
Først lagt ut (Faktiske)
8. september 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
8. september 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
4. september 2026
Sist bekreftet
1. september 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2026/205
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
IPD-planbeskrivelse
Individual participant data are not planned to be shared because no data-sharing plan was established as part of the original study protocol.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .